Beta Bionics, Inc. (BBNX)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
The Development, Manufacture and Sale of The Ilet	100.25M	65.12M	12.00M	179.00K
The Development, Manufacture and Sale of The Ilet Growth	53.94%	442.93%	6601.12%	-
Total	100.25M	65.12M	12.00M	179.00K
Total Growth	53.94%	442.93%	6601.12%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
United States	100.25M	65.12M	12.00M	179.00K
United States Growth	53.94%	442.93%	6601.12%	-
Total	100.25M	65.12M	12.00M	179.00K
Total Growth	53.94%	442.93%	6601.12%	-

Source: S&P Global Market Intelligence.